Vikram Thermo (India) Ltd

AI
Vikram Thermo Summary Chart Analysis Peers Quarters Profit & Loss Balance Sheet Cash Flow Ratios Investors Documents
AI

Vikram Thermo (India) Ltd

₹ 276 5.00%
13 Aug 12:35 p.m.
vikramthermo.com BSE: 530477
About

Incorporated in 1985, Vikram Thermo
Ltd manufactures and sells basic pharma
co-polymers[1]

Key Points

Business Overview:[1]
VTL is an ISO 9001, DRCOAT, and
EXCiPACT International is a GMP-certified, integrated, research-based pharmaceutical excipient company. It manufactures, markets, and exports pharmaceutical excipients and chemicals.

Website BSE
  • Market Cap ₹ 866 Cr.
  • Current Price ₹ 276
  • High / Low ₹ 276 / 132
  • Stock P/E 19.8
  • Book Value ₹ 50.0
  • Dividend Yield 0.36 %
  • ROCE 36.4 %
  • ROE 27.7 %
  • Face Value ₹ 10.0
Edit ratios

Pros

  • Company has reduced debt.
  • Company is almost debt free.
  • Company has delivered good profit growth of 26.3% CAGR over last 5 years
  • Company has been maintaining a healthy dividend payout of 19.4%

Cons

* The pros and cons are machine generated. Pros / cons are based on a checklist to highlight important points. Please exercise caution and do your own analysis.

Peer comparison

Commodities Chemicals Chemicals & Petrochemicals Commodity Chemicals

Edit Columns
Loading peers table ...

Quarterly Results

Figures in Rs. Crores

Jun 2023 Sep 2023 Dec 2023 Mar 2024 Jun 2024 Sep 2024 Dec 2024 Mar 2025 Jun 2025 Sep 2025 Dec 2025 Mar 2026 Jun 2026
22 34 24 27 31 34 34 27 29 35 34 38 38
13 22 15 20 20 21 21 20 17 19 19 26 20
Operating Profit 8 12 9 7 12 12 13 7 11 15 15 12 18
OPM % 38% 36% 39% 27% 37% 37% 39% 25% 40% 45% 44% 32% 48%
0 0 0 -0 -24 -0 -0 1 0 0 0 1 1
Interest 0 0 0 0 0 0 0 0 0 0 0 0 0
Depreciation 1 1 1 1 1 1 1 1 1 1 1 1 1
Profit before tax 8 11 9 6 -13 12 12 7 11 15 15 12 18
Tax % 26% 26% 27% 23% 23% 16% 23% 41% 25% 25% 25% 29% 26%
6 8 6 5 -16 10 9 4 8 11 11 9 13
EPS in Rs 1.83 2.63 2.05 1.57 -5.04 3.12 2.87 1.30 2.53 3.53 3.49 2.71 4.23
Raw PDF

Profit & Loss

Figures in Rs. Crores

Mar 2015 Mar 2016 Mar 2017 Mar 2018 Mar 2019 Mar 2020 Mar 2021 Mar 2022 Mar 2023 Mar 2024 Mar 2025 Mar 2026 TTM
37 38 45 49 58 56 74 93 112 101 126 134 144
32 31 37 44 49 44 55 78 85 64 82 80 84
Operating Profit 5 8 8 5 9 12 18 15 26 37 45 54 61
OPM % 15% 20% 19% 10% 15% 21% 25% 16% 23% 37% 35% 40% 42%
0 0 0 0 0 0 0 1 1 0 -23 2 2
Interest 0 0 0 1 1 1 1 1 1 1 1 0 0
Depreciation 1 1 1 2 2 2 2 3 3 2 3 3 3
Profit before tax 5 6 7 3 6 9 16 12 23 34 18 52 60
Tax % 34% 34% 35% 25% 28% 23% 25% 26% 27% 25% 56% 26%
3 4 5 2 4 7 12 9 17 25 8 38 44
EPS in Rs 1.11 1.51 1.68 0.84 1.58 2.30 3.83 2.76 5.39 8.08 2.58 12.26 13.96
Dividend Payout % 13% 20% 20% 12% 19% 13% 8% 2% 9% 9% 39% 10%
Compounded Sales Growth
10 Years: 13%
5 Years: 13%
3 Years: 6%
TTM: 17%
Compounded Profit Growth
10 Years: 25%
5 Years: 26%
3 Years: 32%
TTM: 34%
Stock Price CAGR
10 Years: 32%
5 Years: 45%
3 Years: 32%
1 Year: 76%
Return on Equity
10 Years: 17%
5 Years: 19%
3 Years: 20%
Last Year: 28%

Balance Sheet

Figures in Rs. Crores

Mar 2015 Mar 2016 Mar 2017 Mar 2018 Mar 2019 Mar 2020 Mar 2021 Mar 2022 Mar 2023 Mar 2024 Mar 2025 Mar 2026
Equity Capital 6 6 6 6 6 6 6 6 31 31 31 31
Reserves 23 27 32 33 37 48 59 67 58 82 90 126
4 1 6 12 14 6 10 15 19 7 6 5
8 8 10 9 9 13 16 16 19 22 18 26
Total Liabilities 41 41 53 60 66 73 92 104 127 143 146 188
10 17 21 30 34 34 32 53 61 61 45 57
CWIP 9 1 7 4 -0 6 18 -0 -0 1 0 0
Investments -0 0 -0 -0 -0 1 10 11 11 15 -0 20
22 22 25 26 32 32 32 40 55 65 101 110
Total Assets 41 41 53 60 66 73 92 104 127 143 146 188

Cash Flows

Figures in Rs. Crores

Mar 2015 Mar 2016 Mar 2017 Mar 2018 Mar 2019 Mar 2020 Mar 2021 Mar 2022 Mar 2023 Mar 2024 Mar 2025 Mar 2026
2 2 6 3 4 13 15 6 13 23 24 52
-3 -1 -10 -8 -2 -10 -19 -7 -13 -9 -22 -41
1 -4 4 4 1 -4 3 3 1 -14 -4 -5
Net Cash Flow -0 -2 -0 -0 3 -1 -1 1 2 -0 -3 5
Free Cash Flow -2 1 -5 -4 2 4 4 -1 0 17 -16 42
CFO/OP 52% 48% 93% 86% 56% 129% 102% 63% 71% 86% 81% 119%

Ratios

Figures in Rs. Crores

Mar 2015 Mar 2016 Mar 2017 Mar 2018 Mar 2019 Mar 2020 Mar 2021 Mar 2022 Mar 2023 Mar 2024 Mar 2025 Mar 2026
Debtor Days 131 139 115 139 138 129 99 93 109 142 128 125
Inventory Days 64 64 98 60 53 97 94 74 64 137 76 87
Days Payable 84 81 102 70 52 107 92 62 69 119 74 104
Cash Conversion Cycle 111 123 111 128 139 119 101 106 104 160 130 108
Working Capital Days 84 145 119 82 84 102 62 72 61 129 122 144
ROCE % 16% 20% 19% 8% 14% 17% 24% 15% 25% 31% 35% 36%

Insights

In beta
Mar 2016 Mar 2017 Mar 2018 Mar 2019 Mar 2020 Mar 2021 Mar 2022 Mar 2023 Mar 2024 Mar 2025
FOB Value of Exports
Rs. in lakhs

Log in to view insights

Please log in to see hidden values.

Login
Permanent Employees
count
R&D Expenditure (% of Total Revenue)
%
Export Revenue Share (% of Total Revenue)
%

Extracted by Screener AI

Shareholding Pattern

Numbers in percentages

Sep 2023Dec 2023Mar 2024Jun 2024Sep 2024Dec 2024Mar 2025Jun 2025Sep 2025Dec 2025Mar 2026Jun 2026
65.94% 65.94% 65.94% 65.94% 65.94% 65.94% 65.94% 66.00% 66.00% 66.00% 66.01% 66.01%
0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.26%
34.06% 34.05% 34.06% 34.05% 34.05% 34.06% 34.06% 33.99% 34.00% 33.99% 34.00% 33.74%
No. of Shareholders 11,08711,28412,22914,53814,12113,98113,64013,30512,72112,16511,73912,055

* The classifications might have changed from Sep'2022 onwards. The new XBRL format added more details from Sep'22 onwards.

Classifications such as banks and foreign portfolio investors were not available earlier. The sudden changes in FII or DII can be because of these changes.

Click on the line-items to see the names of individual entities.

Documents

Announcements

Annual reports

Credit ratings